TEL AVIV, Israel & ZURICH & NEW YORK--(BUSINESS WIRE)--SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine ...
Users in Israel will be able for the first time in the world to perform an at-home Biomarker blood test guided by SHL’s medical team, following ECG tests using The SmartHeart® for Rapid Heart Attack ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback